Optometry Scope of Practice.
The practice of optometry is defined as the examination of the human eye, the examination and ascertaining any defects of the human vision system, and the analysis of the process of vision. The practice of optometry includes:
In order to use topical drugs for diagnostic purposes, an optometrist must have at least 60 hours of didactic and clinical instruction in general and ocular pharmacology for optometry and certification from an institution of higher learning. To prescribe topical drugs, the optometrist must be certified to use topical drugs and have an additional 75 hours of didactic and clinical instruction. To use or prescribe oral drugs for diagnostic or therapeutic purposes, the optometrist must be certified to prescribe topical drugs and have an additional 16 hours of didactic and eight hours of supervised clinical instruction and be certified by an institution of higher education to administer, dispense, or prescribe drugs.
Optometrists are prohibited from prescribing, dispensing, or administering oral corticosteroids and from prescribing an oral drug within 90 days following ophthalmic surgery, unless the optometrist consults with the treating ophthalmologist. Except for the administration of Epinephrine by injection for anaphylactic shock, no injections or infusions may be administered by an optometrist.
Board of Optometry.
The Board of Optometry (Board) consists of three members of the examining committee for optometry and two additional optometrists and one consumer member appointed by the Governor. The optometrist members must be Washington residents, must have been in active practice as a licensed optometrist in Washington for at least four years immediately preceding appointment, and may not have any connection with any optical supply business. The Board must develop and administer or approve a licensure examination. The Board must adopt rules and regulations to promote safety, protection, and the welfare of the public; to carry out the Board's purpose; to aid the Board in the performance of its powers and duties; and to govern the practice of optometry.
Sunrise Review.
In 2021 the Department of Health (DOH) conducted a sunrise review to expand the scope of practice for optometrists in Washington. The proposal made changes to the scope of practice for optometrists including clarifying language regarding what is and is not included in the scope of practice for optometry; granting the Board greater authority over the practice of optometry; expanding the scope of medications and therapeutic procedures an optometrist may prescribe or perform; granting the Board authority for rule-making regarding educational standards; and specifying in an exclusive list which procedures are not considered the practice of optometry. In the final report, the DOH found that aspects of the proposal meet the sunrise criteria, but that the proposal was too broad and did not adequately describe allowed procedures and issued a number of recommendations for ensure patient safety.
Scope of Practice.
The practice of optometry is expanded to specifically include the following in addition to the existing procedures and services:
Advanced Procedures.
With a license endorsement from the Board of Optometry (Board), the practice of optometry may include:
To receive a license endorsement, a licensed optometrist must:
Upon completion of these requirements, proof of training must be submitted to the Board for approval. No optometrist may perform the advanced procedures until the optometrist has received confirmation of the endorsement in writing.
Prescription and Use of Pharmaceutical Agents.
Any optometrist authorized by the Board may purchase diagnostic pharmaceutical agents and is authorized to prescribe therapeutic pharmaceutical agents in the practice of optometry. Optometrists authorized by the Optometry Board to purchase pharmaceutical agents must obtain them from licensed wholesalers or pharmacists, using prescriptions or chart orders placed in the same or similar manner as any physician or other practitioner. Diagnostic and therapeutic pharmaceutical agents are any prescription or nonprescription drug delivered via any route of administration used or prescribed for the diagnosis, treatment, or mitigation of abnormal conditions and pathology of the human eye and its adnexa. Diagnostic and therapeutic pharmaceutical agents do not include Schedule I and Schedule II drugs, except for hydrocodone combination products. The prohibitions on prescribing, dispensing, or administering oral corticosteroids or prescribing an oral drug within 90 days of ophthalmic surgery are removed.
In a public health emergency, the State Health Officer may authorize optometrists to administer inoculations for systemic health reasons.
Prohibited Procedures.
The practice of Optometry does not include:
Board of Optometry.
A full record of the Optometry Board's proceedings must be kept in the Office of the Board and must be open to inspection at all reasonable times. The administrative regulations the Board must adopt must include the classification and licensure of optometrists by examination or credentials, retirement of a license, and reinstatement of a license. The Board shall have the authority to provide rule-making regarding the allowable procedures and their educational requirements for optometry. The Board must keep a registrar containing the name, address, license number, email, and phone number of every licensed optometrist to the best of the Board's ability.